Literature DB >> 3135797

Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions.

J Chmielewska1, M Rånby, B Wiman.   

Abstract

The reactions between plasminogen-activator inhibitor (PAI) and different plasminogen activators were studied in the presence of chromogenic peptide substrates for the enzymes. Our findings suggest that the rate constants for the reactions of PAI with single-chain tissue plasminogen activator (tPA), two-chain tPA, high-Mr urokinase and low-Mr urokinase are high and quite similar (1.6 X 10(7)-3.9 X 10(7) M-1.s-1). A free active site in the enzymes seems to be necessary for their reaction with PAI. Amino acids with antifibrinolytic properties did not interfere with the reactions. However, di-isopropyl phosphorofluoridate-inactivated tPA inhibited the reaction between PAI and all plasminogen activators in a similar way. These findings clearly demonstrated that a 'second-site' interaction, in addition to that between the enzyme active site and the inhibitor 'bait' peptide bond, is of importance for the high reaction rate. The reaction rate between PAI and single-chain tPA in the presence of an activator substrate (D-Ile-Pro-Arg p-nitroanilide) was decreased in the presence of fibrin. Fibrin caused a decrease in the Km for the single-chain tPA-substrate reaction. As a consequence, the 'free' concentration of single-chain tPA in the system decreased in the presence of fibrin, affecting the reaction rate between PAI and single-chain tPA. The phenomenon might be of physiological relevance, in the sense that single-chain tPA bound to fibrin in the presence of plasminogen would be protected against inactivation by PAI.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135797      PMCID: PMC1149006          DOI: 10.1042/bj2510327

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  On the kinetics of the reaction between human antiplasmin and plasmin.

Authors:  B Wiman; D Collen
Journal:  Eur J Biochem       Date:  1978-03-15

2.  The active and the inactive plasminogen activator inhibitor from human endothelial cell conditioned medium are immunologically and functionally related to each other.

Authors:  E D Sprengers; V W van Hinsbergh; B G Jansen
Journal:  Biochim Biophys Acta       Date:  1986-09-04

3.  Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.

Authors:  T Ny; M Sawdey; D Lawrence; J L Millan; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells.

Authors:  E G Levin
Journal:  Blood       Date:  1986-05       Impact factor: 22.113

5.  Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivo.

Authors:  M Colucci; J A Paramo; D Collen
Journal:  J Lab Clin Med       Date:  1986-07

6.  Determination of tissue plasminogen activator and its "fast" inhibitor in plasma.

Authors:  J Chmielewska; B Wiman
Journal:  Clin Chem       Date:  1986-03       Impact factor: 8.327

7.  Comparison of plasminogen activator inhibitor activity and antigen in plasma samples.

Authors:  G Urdén; A Hamsten; B Wiman
Journal:  Clin Chim Acta       Date:  1987-11-16       Impact factor: 3.786

8.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

9.  Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma.

Authors:  E K Kruithof; C Tran-Thang; A Ransijn; F Bachmann
Journal:  Blood       Date:  1984-10       Impact factor: 22.113

10.  Studies on the release of a plasminogen activator inhibitor by human platelets.

Authors:  E K Kruithof; C Tran-Thang; F Bachmann
Journal:  Thromb Haemost       Date:  1986-04-30       Impact factor: 5.249

View more
  10 in total

Review 1.  Molecular basis of thrombolytic therapy.

Authors:  H R Lijnen; D Collen
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

2.  Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones.

Authors:  Paul A Lapchak; Jacqueline M Lara; Paul D Boitano
Journal:  Transl Stroke Res       Date:  2017-04-12       Impact factor: 6.829

Review 3.  Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Authors:  Franco Scaldaferri; Stefano Lancellotti; Marco Pizzoferrato; Raimondo De Cristofaro
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

4.  The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator.

Authors:  T L Lindahl; P I Ohlsson; B Wiman
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

5.  Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis.

Authors:  Yacine Boulaftali; Benoit Ho-Tin-Noe; Ana Pena; Stéphane Loyau; Laurence Venisse; Déborah François; Benjamin Richard; Véronique Arocas; Jean-Philippe Collet; Martine Jandrot-Perrus; Marie-Christine Bouton
Journal:  Circulation       Date:  2011-03-14       Impact factor: 29.690

6.  Functional effects of single amino acid substitutions in the region of Phe113 to Asp138 in the plasminogen activator inhibitor 1 molecule.

Authors:  G C Sui; B Wiman
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

7.  Investigating the two regimes of fibrin clot lysis: an experimental and computational approach.

Authors:  Franck Raynaud; Alexandre Rousseau; Daniel Monteyne; David Perez-Morga; Karim Zouaoui Boudjeltia; Bastien Chopard
Journal:  Biophys J       Date:  2021-08-10       Impact factor: 3.699

8.  Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system.

Authors:  M Laurell; A Christensson; P A Abrahamsson; J Stenflo; H Lilja
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

9.  Thrombosis in inflammatory bowel diseases: what's the link?

Authors:  Martina Giannotta; Gherardo Tapete; Giacomo Emmi; Elena Silvestri; Monica Milla
Journal:  Thromb J       Date:  2015-04-02

10.  The role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis.

Authors:  Maja Zivković; Nada Starčević Čizmarević; Luca Lovrečić; Inge Klupka-Sarić; Aleksandra Stanković; Iva Gašparović; Polona Lavtar; Evica Dinčić; Ljiljana Stojković; Gorazd Rudolf; Saša Sega Jazbec; Olivio Perković; Osman Sinanović; Juraj Sepčić; Miljenko Kapović; Borut Peterlin; Smiljana Ristić
Journal:  Dis Markers       Date:  2014-04-16       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.